Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Sapanisertib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sensei Biotherapeutics Doses First Patient in PIKTOR Trial
    Sensei Biotherapeutics Doses First Patient in PIKTOR Trial

    05 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-05/sensei-biotherapeutics-doses-first-patient-in-phase-1b2-trial-of-piktor-in-hrplusher2-advanced-breas

    PHARMIWEB
    05 May 2026
    Share Share
    Faeth Therapeutics' Phase 2 DICE Trial Reveals 34% Lower Disease
    Faeth Therapeutics' Phase 2 DICE Trial Reveals 34% Lower Disease

    19 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-19/esmo-2025-faeth-therapeutics-phase-2-dice-trial-shows-34-reduction-in-risk-of-disease-progression

    PHARMIWEB
    19 Oct 2025
    Share Share
    Faeth Therapeutics and GOG Foundation Launch Phase 2 Trial
    Faeth Therapeutics and GOG Foundation Launch Phase 2 Trial

    12 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250312383430/en

    BUSINESSWIRE
    12 Mar 2025
    Share Share
    Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase
    Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase

    17 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240717288408/en

    BUSINESSWIRE
    17 Jul 2024
    Share Share
    Calithera Receives FDA Fast Track Designation for Sapanisertib
    Calithera Receives FDA Fast Track Designation for Sapanisertib

    03 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/03/2526655/0/en/Calithera-Receives-FDA-Fast-Track-Designation-for-Sapanisertib-for-the-Treatment-of-NRF2-mutated-Squamous-Lung-Cancer.html

    GLOBENEWSWIRE
    03 Oct 2022
    Share Share
    Calithera Biosciences Reports Second Quarter 2022 Financial Results
    Calithera Biosciences Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/15/2498526/32478/en/Calithera-Biosciences-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    15 Aug 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.